Autopsy report · NCT02258867
Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year before it stopped.
- 4 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- XOMA (US) LLC
- Sponsor type
- Industry
- Conditions
- Behcet's Disease Uveitis
- Interventions
- Placebo; Gevokizumab
- Participants
- 4
- Sites
- 8
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.